Machine signal
Active cluster sell — 4 distinct insiders, $26.5M, window ends Sep 4, 2026.
Figures computed from official regulatory filings — .
Analysttarget 392.11 USD (+22%) · consensus 4.75/5 · 11 buy · 1 hold · 0 sell
Ownershipinsiders 10.66% · institutions 102.51% · short 17.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Krystal Biotech, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
11 buys559 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| ROSSI DINO A | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mazzacco Catherine | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mason Christopher | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gangolli Julian S | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gangolli Julian S | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| JANNEY DANIELtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mason Christopher | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sutherland Everett Rand | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ROSSI DINO A | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| JANNEY DANIELtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sutherland Everett Rand | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mazzacco Catherine | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Krishnan Sumatrack record | Sell | $1.4M | SEC |
| Krishnan Sumatrack record | Sell | $146.3K | SEC |
| Krishnan Sumatrack record | Sell | $1.2M | SEC |
| Krishnan Krish Strack record | Sell | $1.2M | SEC |
| Krishnan Krish Strack record | Sell | $816.8K | SEC |
| Krishnan Krish Strack record | Sell | $495K | SEC |
| Krishnan Krish Strack record | Sell | $208.2K | SEC |
| Krishnan Sumatrack record | Sell | $449.1K | SEC |
| Krishnan Sumatrack record | Sell | $205.3K | SEC |
| Krishnan Sumatrack record | Sell | $1.2M | SEC |
| Krishnan Krish Strack record | Sell | $439K | SEC |
| Krishnan Krish Strack record | Sell | $309.5K | SEC |
| Krishnan Krish Strack record | Sell | $721.5K | SEC |